• Mashup Score: 0
    NephSIM Nephrons - - 5 month(s) ago

    NephSIM Nephrons is proud to announce a new partnership with the National Kidney Foundation! Applications for the 2024 Program are now open! Apply here by November 15th 5PM ET.            What is NephSIM Nephrons? The goal of the 6-month NephSIM Nephrons virtual mentoring program (January – June) is to provide tailored nephrology […]

    Tweet Tweets with this article
    • 📢 Calling all ned students & residents interested in nephrology, join the @Neph_SIM Nephrons Program! 🗓️ Jan - June 2024 🤝 Personal Mentorship 📖 Asynchronous Learning 👥 Small Group Interaction Apply by Nov 15, 2023, 5pm ET Details & application: https://t.co/q1xs1uEha1 https://t.co/ZKX3kQoDxK

  • Mashup Score: 1

    Nearly one-third of dialysis clinics completed training on care coordination and care transitions when it was offered, according to a study published in Kidney Medicine.“For the everyday clinician, our findings underscore the necessity of understanding the pivotal concepts related to care coordination and mental health within the dialysis facility context,” Amber B. Paulus, PhD, RN,

    Tweet Tweets with this article
    • 🔉Study: One-third of #dialysis clinics 🏥completed training on care coordination and care transitions when offered. Read more here ⬇️: https://t.co/avjV8vZHOZ

  • Mashup Score: 1

    Most people receiving dialysis are hospitalized in the last month of life, and nearly half of them undergo intensive care.1 Although hospice positively impacts end-of-life outcomes,2 patients receiving dialysis are half as likely to receive hospice services compared to the general Medicare population.3 Limitations of the Medicare hospice benefit, which requires hospices to cover the cost of care related to the terminal diagnosis, may serve as a barrier to timely hospice access. We previously described outcomes of a concurrent hospice-dialysis program that allows patients to continue comfort-focused dialysis while receiving hospice.

    Tweet Tweets with this article
    • Perspectives of Caregivers and Clinicians on a Concurrent Hospice and Dialysis Program: A Qualitative Analysis https://t.co/4AZ1oJkPYR (FREE) @keithlagnese @JaneSchell11 @PITTRenal https://t.co/qWwidC5vVm

  • Mashup Score: 0

    At the NKF Spring Clinical Meetings, the Editors present “Highlights from AJKD” featuring new research published in AJKD. They also announce the winner of the annual NKF Mission Award, which recognizes research with great promise to enhance the lives of those affected by kidney disease. Deputy Editor Tara I. Chang and Associate Editors James Kaufman and Elaine Ku presented on the following topics: kidney disease in older adults, acute kidney injury, and pediatrics. To claim CME, please register/log in at

    Tweet Tweets with this article
    • Deputy Editor @taraichang along with Associate Editors James Kaufman and Elaine Ku present Highlights from AJKD in the following topics: - kidney disease in older adults - AKI - pediatrics https://t.co/wyhGrEpDCw CME available until July 17, 2024! @NKF_NephPros https://t.co/89xAHj2Fxl

  • Mashup Score: 0

    D3 is a master energy regulator of the intracellular purinergic hypoxic compensatory response that promotes rapid energy supply from extracellular adenosine, eAMPK-dependent metabolic reprogramming, and O2 delivery, which combat renal hypoxia and progression of CKD. ENT1-AMPD3-AMPK-BPGM comprise a group of circulating erythroid-specific biomarkers, providing early diagnostic and novel therapeutic targets for CKD. Background Hypoxia drives kidney damage and progression of CKD. Although erythrocytes respond rapidly to hypoxia, their role and the specific molecules sensing and responding to hypoxia in CKD remain unclear. Methods Mice with an erythrocyte-specific deficiency in equilibrative nucleoside transporter 1 (eEnt1−/−) and a global deficiency in AMP deaminase 3 (Ampd3−/−) were generated to define their function in two independent CKD models, including angiotensin II (Ang II) infusion and unilateral ureteral obstruction (UUO). Unbiased metabolomics, isotopic adenosine flux, and vario

    Tweet Tweets with this article
    • Erythrocyte ENT1-AMPD3 axis is an essential purinergic hypoxia sensor and energy regulator. Studies in mouse suggest potential to combat CKD https://t.co/nd4dDF5OIR https://t.co/PEdteyt8Gw

  • Mashup Score: 0

    In a recent editorial, Beatrice Concepcion, MD, wrote despite some challenges, transplantation “remains the treatment of choice for most patients with advanced kidney disease,” offering a better quality of life compared with dialysis.Administrators of the Medicare End-Stage Renal Disease Program see kidney transplants as more cost effective compared with dialysis and encourage the

    Tweet Tweets with this article
    • 🔊 With limited funding, researchers move forward on bioartificial kidneys, xenotransplants. #artificialkidney #nephrology #transplantation Read the Healio Exclusive here: 🔽https://t.co/6doiUm3SS8